logo

Q301--Q&A Cytopathology And Next Generation Sequencing Testing Services Close 08/21/2026 17:00

Sector: Hospital • Location: United States of America

Source: SAM.gov

Tender
Combined Synopsis/Solicitation

This amendment 0001 publishes the Government s responses to all vendor questions submitted by the deadline of 5:00 PM on August 13, 2026, and issues the revised Performance Work Statement (PWS) reflecting clarifications and updates resulting from the Q&A review

Status
Prospective
Sector
Hospital, Government, Residential, Commercial
Location
United States of America
Updated
3 Nov 2026
Source
SAM.gov

ConstructChat

Ask ConstructChat about Q301--Q&A Cytopathology And Next Generation Sequencing Testing Services Close 08/21/2026 17:00

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

3 Q
The tender “Q301--Q&A Cytopathology And Next Generation Sequencing Testing Services Close 08/21/2026 17:00” is a tender record in Taiyo, linked to the Hospital sector. It is issued for works, goods, or services related to United States of America.

Participants

Not available for this record.

Status

Original status

combined synopsis/solicitation

Taiyo status

Prospective

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

This amendment 0001 publishes the Government s responses to all vendor questions submitted by the deadline of 5:00 PM on August 13, 2026, and issues the revised Performance Work Statement (PWS) reflecting clarifications and updates resulting from the Q&A review

Original sector

Health Care and Social Assistance

Location

Country

United States of America (USA)

Source

Source

SAM.gov

URL

More Details

Record type

Tender

Sector

Hospital, Government, Residential, Commercial

Article published date

2026-08-20

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender